Abstract
Considering the achievements of the CTC, the investigators agreed to focus our research efforts for the next 6 years in three main cell types: mesenchymal stromal cells (MSC); genetically modified lymphocytes (including CAR-T cells) and other immunocompetent cells) and hematopoietic stem cells (HSC). Research is outlined according to the stage of development: pre-clinic, clinic, and technology transfer. The pre-clinic stage also involves the pathogenesis of hematological diseases candidates that are for cell therapy as well as the study of the bone marrow (BM) niche and development of in vitro and in vivo models to test cell therapy. (AU)
| Articles published in Agência FAPESP Newsletter about the research grant: |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |